Health
Call for Applications: CTCA Study Coordinator (Nov 2021-Nov 2026)
Published
5 years agoon

Project Title
Quit4Life+: Adapting and Evaluating a Phone-Based Tobacco Use Cessation Program for People Living with HIV in Uganda and Zambia
Introduction
The Centre for Tobacco Control in Africa is open for applications from suitably qualified candidates to coordinate a 5-years study in the field of HIV, tobacco use cessation and mHealth. The project targets young professional with a background in Public Health and clinical medicine from recognized university or any other related field institutions. The candidate should be interested in furthering research skills in the domains of HIV, tobacco control, mHealth, clinical trials and desirous of pursuing a PhD. The project provides opportunities for PhD.
About the Project
The Centre for Tobacco in Africa (CTCA), a constituent entity of Makerere University School of Public health responsible for capacity building and research for tobacco control in Africa. CTCA and the University of Southern California (USC) will be implementing a 5-year research project titled “Quit4Life+: Adapting and Evaluating a Phone-Based Tobacco Use Cessation Program for People Living with HIV in Uganda and Zambia”. This randomized control trial study aims to promote smoking cessation among HIV infected persons through adapting a standard short message service (SMS) for tobacco cessation program and the efficacy of SMS-based program tailored to meet the needs of PLWH (Quit4Life+) in comparison to the current standard of care in Uganda and Zambia.
The study will provide insights into the efficacy, feasibility, and applicability of delivering tobacco cessation interventions through health care professionals at HIV treatment centers in two countries with different tobacco use patterns, policy environments, and health care resources and provide needed information to providers and policymakers looking for cost-effective tobacco cessation interventions to inform scale-up of tobacco use cessation in LMICs worldwide. The project is therefore targeting public health professionals with experience in clinical trials and interested in fortifying their research skills who want to do a PhD.
While the PhD sponsorship is not embedded in the study, the project provides opportunities for a 5-year hands-on practicum the study coordinator will optimize to further his/her research and writing skills. The study coordinator will be expected to participate in teaching and to co-mentoring students interested to conduct research in the fields covered by the study. The candidate will be assigned an academic mentor from within the study team to further his/her career objective.
Scope of Work
The objective of recruiting a study coordinator is to strengthen coordination of the study to attain the project deliverables in the projected timelines. Therefore, the project seeks to recruit a professional responsible for holding the research program together in support of the project goal and specific aims to understand tobacco use cessation among HIV positive clients in health care settings. The search is for a full-time professional to hold the different components of the research project linked and desirous of undertaking a PhD. The successful individual will undergo a 6 months’ probation. The contract is renewable after successful performance appraisal for up to 5 years. In fulfilment of the PhD support, part of the individual salary will pay his/her tuition at Makerere University. The individual will use data from the project to write his/her thesis and also participate in the capacity building activities/session at the School of Public Health.
The study coordinator will;
- Develop the quarterly and annual work plans for the project
- Draft communication letters and memos for signature by the PI or his/her designate
- Schedule and convene virtual/physical meetings
- Act as secretary for the meetings
- Prepare terms of reference and job descriptions of project staff including field research teams
- Coordinate research capacity building activities and keep liaison with the study site teams in the two countries
- Ensure the study tools are up to date and protocols are submitted to IRB including renewals
- Support the procurement of the needed equipment to conduct the data collection
- Field supervision of study activities
- Supervision and appraisal of research assistants
- Overseeing data management and analysis, maintain, and update the research database for ease of follow up and reference
- Ensure quality assurance of the data collected
- Tracking progress against targets and documenting the study progress for timely and quality research outputs
- Preparing and submitting weekly progress reports to the PI
- Planning and management tasks for the smooth running of the research project.
- Track progress against targets and document the study process through compilation of monthly reports
- Coordinate the consent disclosure language and authorization, data collection, management, analysis and transmission
- Generate activity plans and the requisite operational schedules.
- Participate in preparation of manuscripts for publication in scientific journals.
- Compile monthly, quarterly, and annual report for review by the PI
- Participate is translating research outputs into peer reviewed journal articles, manuscripts, and publications.
- Organize dissemination of research information through various dissemination channels
- Any other duties related to the study that may be assigned by the PI
Key deliverables along the project path
The required deliverables include;
- Study tools
- Quarterly and annual work plans & budgets
- Performance Reports; Monthly, quarterly annual
- Term of references for the various level of the project team
- Checklists of project team
- A publication per year
- Supervision of students at master’s level
- Submission of a research grant for funding
- A PhD dissertation
Application Procedures
The applicant should submit electronically by 15th January 2022 at 5.00pm EAT;
- A cover letter
- A detailed Curriculum Vitae highlighting relevant research experience
- Copies of academic transcripts
- A statement of motivation that indicates reasons for applying for this post
- Reference letters from two referees with active phone numbers, and email addresses
- Address your application EOI[at]ctc-africa.org
Preference will be given to applicants interested in pursuing a PhD and demonstrated ability to contribute to the overall project goal.
Call originally posted on CTCA website
You may like
-
Makerere University Hosts Deputy IGG Ahead of Ombuds Day 2026
-
Mak, CoRE-MATH Project Partners Develop Models to Address Regional Development Challenges
-
MakSPH reseachers calls for health data to be used in decisions
-
UPHIA 2025 Shows Uganda’s HIV Status Awareness Gap Despite Strong Treatment Outcomes
-
Beyond Map Size: Africa’s Agency Should Not Be Funded by Other People
-
JNLC Leadership Symposium Equips Young Leaders for Responsible and Transformative Leadership
Health
Uganda’s HIV Treatment Gains Bring the Youth Gap into Focus
Published
1 day agoon
October 5, 2026
Uganda’s latest national HIV survey reveals lower viral suppression among adolescents and young adults living with HIV than among older adults, even as the country records substantial improvements in controlling the virus. The findings come from Uganda Population-Based HIV Impact Assessment (UPHIA 2025), a national household survey examining HIV prevalence and whether people living with the virus know their status, receive treatment, and achieve viral suppression.
Releasing the preliminary UPHIA 2025 findings at the Uganda Media Centre on 1 October 2026, Minister of Health Hon. Dr. Chris Baryomunsi called for earlier prevention and testing, particularly among adolescent girls and young women, alongside support for treatment adherence. “We must reach out to the young people, ensure that they have information, they test, take treatment, and adhere to the treatment guidance,” he urged.
Hon. Baryomunsi recalled how fear had discouraged testing during his university years: “I remember when we were at university, we went for testing at the university hospital. We sat there for three hours. Some of us left without even testing because it was scary.” Today, he explained, “even if you test HIV positive, you can be initiated on treatment, and you live normally like the rest of those who don’t have HIV.”

UPHIA 2025 was locally led under the Ministry of Health’s overall leadership, with Makerere University School of Public Health serving as the prime implementer, a role ICAP at Columbia University held in the previous two surveys. The Uganda Bureau of Statistics led sampling, while the Uganda Virus Research Institute and National Health Laboratory and Diagnostic Services led laboratory operations. Regional referral hospitals and local governments supported implementation, and the U.S. government provided US$10 million through PEPFAR, along with technical assistance from the U.S. CDC.
UPHIA collected data from July to September 2025 among people aged 15 and above, including those outside routine treatment services. Of 6,283 eligible households, 94.4% completed interviews. Researchers interviewed 13,801 people and tested 13,477 for HIV.
Testing followed Uganda’s national algorithm, with laboratory confirmation of positive samples, viral-load measurement, and checks for antiretroviral medicines to establish treatment use. Researchers weighted the estimates to account for the sampling design. Participants received counselling and results, and those who tested positive were referred for treatment.
Hon. Baryomunsi thanked participants and their families for welcoming survey staff and contributing their time, information and samples, without which the national evidence would not have been available.

National progress and the youth gap
The survey estimated HIV prevalence, which means the proportion of people living with HIV, at 5.9% among those aged 15 and above, corresponding to about 1.496 million people in this age group nationwide. Prevalence was 7.3% among women and 4.1% among men, ranging from 1.3% in Karamoja to 8% in the South Western region.
Among people aged 15 and above living with HIV, 86% had achieved viral suppression, meaning a low amount of HIV in the blood, measured in UPHIA as fewer than 1,000 copies per millilitre. Suppression stood at 69.3% among adolescents and young adults aged 15–24 living with HIV, compared with 89.9% among those aged 50 and above. These estimates cover people living with HIV regardless of whether they know their status or receive treatment.

HIV prevalence among people aged 15–24 was 1.5%, including 2% among young women and 1% among young men. Among young women, prevalence was 1.3% at ages 15–19 and 2.8% at ages 20–24. These differences support attention to earlier prevention and testing, although they do not establish when infections occurred.
The highest prevalence estimates occurred among middle-aged adults: 15.7% among women aged 40–44 and 11.7% among men aged 45–49. Lower suppression among young people therefore requires attention alongside the higher HIV prevalence among middle-aged adults. Comparing the same age group across both surveys, viral suppression among people aged 15–64 increased from 74.9% in 2020–21 to 86.1% in 2025, while HIV prevalence remained at 5.9%.

Diagnosis and the path to 2030
The treatment results identify diagnosis as the main national gap. Among people aged 15 and above living with HIV, 85.3% knew their status. Of those aware, 99.1% were receiving treatment; among those receiving treatment, 96.5% had achieved suppression.
The 95-95-95 targets aimed for 95% of people living with HIV to know their status, 95% of those diagnosed to receive treatment, and 95% of those receiving treatment to achieve viral suppression by 2025. Among people aged 15 and above, Uganda exceeded the treatment and suppression targets, while diagnosis remained below target. UNAIDS’s Global AIDS Strategy 2026–2031 retains these targets towards ending AIDS as a public health threat by 2030.
According to WHO, viral suppression protects health and helps prevent HIV transmission. Uncontrolled HIV weakens the immune system, increasing the risk of serious illness. With continued treatment as prescribed, sexual transmission risk is negligible when HIV remains suppressed but detectable, and zero when undetectable. The Uganda AIDS Commission estimated over 34,000 new HIV infections in 2025, underscoring the importance of early diagnosis, timely treatment, and sustained suppression alongside other prevention measures.

The demographic stakes are substantial. People aged 15–24 constituted 21.2% of Uganda’s population in the 2024 census. The country’s Fourth National Development Plan, covering 2025–2030, prioritises a healthy, knowledgeable, skilled and productive population and reducing HIV through primary health care. Protecting young people’s health, therefore, supports their participation in education, work, and national development; UPHIA helps identify where services need greater attention.
Turning evidence into action
The study’s conclusions identify three priorities: sustain treatment outcomes, find people unaware of their status, and improve suppression among younger people. Permanent Secretary Dr. Diana Atwine connected the findings to the Ministry’s planning.
“We do believe that these results are a true reflection of what is happening in our country as far as the HIV status is concerned, and we do believe that it will give us a very clear direction and the roadmap that we are going to take in the next five years to target and to get our targets achieved.”

Acting on these priorities requires funding for services and research. Hon. Baryomunsi outlined plans to target resources where needs are greatest, strengthen district services and align partner support with government priorities. Responding to journalists’ questions, he noted the government’s intention to increase domestic funding for the HIV response, including research.
“The HIV/AIDS response, including research and surveys such as this one, has largely been funded by partners in the past. The government of Uganda is committed to allocating more resources from our domestic budget to support the response and research,” he noted.
For the first time in the UPHIA series, the survey assessed selected noncommunicable disease indicators among people aged 15 and above: 15.5% had elevated blood pressure, 24.8% were overweight or obese, and 0.9% had raised random blood glucose. These screening findings align with the Ministry’s integration agenda and Hon. Baryomunsi’s call to bring HIV and chronic care services together to address people’s wider health needs.
Speaking at the release of the preliminary results, U.S. Embassy Chargé d’Affaires Mikael (Mika) Cleverley described UPHIA 2025 as the first Population-Based HIV Impact Assessment worldwide fully led and implemented by the country itself.

“The study was led by Ugandan scientists, Ugandan managers, Ugandan public servants, Ugandan field teams, from design to data collection to analysis. And this is what two decades of focused strategic U.S. foreign investments in the public health sector was meant to produce, is to reinforce Ugandan leadership and Ugandan-led efforts.”
At the survey launch on 29 May 2025, MakSPH Dean Prof. Rhoda Wanyenze highlighted the partnership’s contribution: “The partnership between Makerere University and CDC has not only helped build national capacity in surveillance and epidemiology, but has also strengthened our ability to lead high-quality, large-scale national surveys.”

The Dean added: “After two decades of joint work, we are proud that UPHIA is now a fully Ugandan-led effort. This is critical to the sustainability of the skills and knowledge generation to inform our local response.”
UPHIA 2025 shows how far Uganda’s HIV response has advanced and where gaps remain. As the country works towards ending AIDS as a public health threat by 2030, reaching young people with testing, treatment, and continued care will be essential to extending those gains.

Read the full UPHIA 2025 summary results here:
Health
MakSPH reseachers calls for health data to be used in decisions
Published
4 days agoon
October 2, 2026
Health experts from across Africa have called for stronger use of routine health data in planning, supervision and service delivery, noting that although countries are generating large amounts of health information, much of it is still not being used.
The call came during a webinar hosted by the Makerere University School of Public Health (MakSPH) in partnership with The Global Fund under the theme “From National Dashboards to District Action: Strengthening Subnational Data Use for Planning, Supervision and Service Delivery.”
The webinar brought together health information specialists, policymakers and practitioners from Uganda, Kenya, Zimbabwe and Ethiopia to share experiences and lessons on using subnational data for evidence based decision making.
Kenya’s journey from data collection to action
In her keynote address, Dr Helen Kiarie, Head of the Monitoring and Evaluation Division at Kenya’s Ministry of Health, urged health practitioners and policymakers to move beyond routine reporting and use data to improve health outcomes.
“The bottleneck is no longer collecting data. It is turning routine data into decisions and decisions into action,” Dr Kiarie said.
Drawing on Kenya’s experience, she pointed to the country’s shift from paper based reporting systems to digital platforms, noting that more than 95% of public health facilities have been digitised.
According to Dr Kiarie, Kenya has developed National Data Analytics Guidelines to support evidence based decision making across the health system. The guidelines set out a structured approach to data analysis, interpretation and dissemination so that the information generated can be used.
She said building a culture of data use requires leadership that asks for evidence, regular performance reviews, public dashboards, mentorship programmes, and the integration of data into planning and budgeting.
Community data improving maternal health
Dr Kiarie gave practical examples of how data can shape health outcomes.
In Kwale County, community health promoters used household level data to identify and follow up pregnant women, encouraging them to attend antenatal care services and deliver at health facilities.
As a result, skilled birth attendance increased from 50 per cent in 2022 to 85 per cent, while reported home deliveries fell from 808 to 248.
She also pointed to Kenya’s efforts to link digital health data with health financing systems, saying better documentation and data quality have strengthened accountability and increased reimbursements to health facilities.
She added that real time maternal and perinatal death surveillance systems are helping health authorities identify gaps in care, assign responsibility and take corrective action to prevent avoidable deaths.
“Data has moved beyond documenting losses to becoming an instrument for preventing the next avoidable death,” Dr Kiarie said.
Addressing data quality challenges
Despite major investments in digital health systems, Dr Kiarie acknowledged that data quality challenges remain.
She cited system downtimes, the parallel use of paper and digital records, limited access to some digital platforms, and resistance to change among some health workers as barriers to data quality and use.
Still, she said Kenya’s data quality has improved considerably through digitisation and continued investment in governance, analytics capacity and quality assurance.
Regional experiences and lessons
The webinar also included a panel discussion with experts from Uganda, Zimbabwe and Ethiopia, who shared experiences on strengthening data use at district and facility level.
The discussion pointed to the importance of strong leadership, timely information, digital infrastructure and feedback mechanisms that help health workers and managers make informed decisions with the data available.
Participants agreed that health information systems should do more than serve as reporting tools. They should also support decision making where services are delivered.
Moving from information to impact
Speaking during the webinar, Prof. Rhoda Wanyenze, Dean of Makerere University School of Public Health (MAKSPH), commended countries for progress in strengthening health information systems and encouraging data use.
She urged practitioners and researchers to go beyond documenting challenges and start capturing examples of how data informed decisions are improving programmes and health outcomes.
“It would be really good for us to dig deeper in terms of what decisions we have actually made and what we would not have known or done differently if we did not have the data,” she said.
In his closing remarks, Dr Wodimu Ayele of The Global Fund said the value of data lies in its ability to improve service delivery, inform decision making and strengthen accountability.
He called on countries to keep investing in data quality, analytics capacity and health information systems, while making sure evidence generated at all levels leads to measurable improvements in health outcomes.
Health
UPHIA 2025 Shows Uganda’s HIV Status Awareness Gap Despite Strong Treatment Outcomes
Published
5 days agoon
October 1, 2026
Uganda has released the preliminary findings of the 2025 Uganda Population-Based HIV Impact Assessment (UPHIA 2025), a national household survey that provides a current picture of the country’s HIV response and selected non-communicable disease indicators.
At the Uganda Media Centre today, 1 October 2026, the Minister of Health, Hon. Dr Chris Baryomunsi, released the preliminary results and said the evidence would guide policy, resource allocation and service improvement, with particular attention to people and communities with the greatest gaps. He urged Ugandans to know their HIV status, use prevention services and, when diagnosed, start treatment promptly and adhere to it.

Among adults aged 15 years and above, HIV prevalence was 5.9 percent, including 7.3 percent among women and 4.1 percent among men. Among adults aged 15–64, prevalence was also 5.9 percent, unchanged from 2020/21. Across the country, prevalence ranged from 1.3 percent in Karamoja to 8.0 percent in the South Western region. Of adults living with HIV, 85.3 percent knew their status; 99.1 percent of those aware were on treatment; and 96.5 percent of those on treatment had achieved viral load suppression. HIV-status awareness remains the central gap in the 95-95-95 cascade.
The survey also measured selected non-communicable disease indicators for the first time. Elevated blood pressure affected 15.5 percent of adults, while 24.8 percent had overweight or obesity and 0.9 percent had raised blood glucose.

Conducted from July to September 2025, UPHIA 2025 was the first population-based HIV impact assessment to be fully country-led. The Ministry of Health provided overall leadership, while Makerere University School of Public Health served as the prime implementing organisation, working with UVRI, UBOS, regional referral hospitals and local governments. PEPFAR funded the survey through the U.S. CDC.
Watch the UPHIA 2025 preliminary results launch:
https://www.youtube.com/live/QfHFBaJ-L-w
Read the UPHIA 2025 summary results:
https://drive.google.com/file/d/1nElGNwgcAcZyAo9CLCQKRpO2jJgyxjSc/view?usp=drive_link
Trending
-
General2 weeks agoCall for Applications: RLRH Graduate Traineeship Programme
-
General5 days agoStatement on Concerns Circulating Regarding a Member of Academic Staff
-
Research2 weeks agoCall for Makerere Staff PhD Completion Grant Applications, 2026-27
-
Engineering, Art & Tech2 weeks agoPublic Art Talk Sparks Dialogue on Contemporary Art Practices at MTSIFA
-
General1 week agoMakerere Marathon 2026 – Running to Equip the Disability Support Center